Bacterial thiamine biosynthetic and salvage enzymes

Bacterial enzymes involved in thiamine utilization and related metabolic pathways are essential for the production of thiamine pyrophosphate (TPP), a critical cofactor for enzymes in the Krebs cycle and pentose phosphate pathway (Source: PubMed, PMID: 21830957). These enzymes, including thiamine phosphate synthase (ThiE) and hydroxymethylpyrimidine kinase (ThiD), facilitate the de novo synthesis or salvage of thiamine, which is vital for bacterial energy metabolism and survival (Source: UniProt, P0AD59). Because humans lack the de novo thiamine biosynthetic pathway and rely on dietary intake, these bacterial enzymes represent promising targets for selective antimicrobial development (Source: PubMed, PMID: 19108086). Inhibition of these targets by thiamine analogs like pyrithiamine or amprolium leads to TPP depletion, resulting in metabolic arrest and bacterial death (Source: PubChem, CID 2168). Furthermore, regulatory elements such as thiamine riboswitches often control the expression of these enzymes, providing additional points for therapeutic intervention (Source: PubMed, PMID: 26854131).

Other names

Thiamine utilization enzymesBacterial Vitamin B1 metabolic pathwayThi-pathway enzymesThiamine biosynthesis enzymesThiamine metabolic enzymes

Inhibition of enzymes within the thiamine biosynthetic or salvage pathways, or competitive antagonism of thiamine utilization, leading to the depletion of thiamine pyrophosphate (TPP) and subsequent metabolic arrest.